Delaware Health News Online: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Delaware Health News Online.

Press releases published on August 19, 2026

Aug. 19, 2026

BioTek reMEDys Selects TJM Labs to Automate Specialty Pharmacy Benefits Verification

Indeterminate EIN Presswire

Aug. 19, 2026

PumasAI Launches New Clinical Pharmacology Webinar Series Showcasing End-to-End AI-Powered PK Analysis

Indeterminate EIN Presswire

16 hours ago

Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

17 hours ago

Picard Medical Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

18 hours ago

Ultragenyx Announces U.S. FDA Approval of GENGLYCOS™ Gene Therapy, the First-Ever FDA-Approved Treatment Designed to Treat the Underlying Cause of Glycogen Storage Disease Type Ia (GSDIa)

Indeterminate GlobeNewswire

18 hours ago

Solésence Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

18 hours ago

MedPro Healthcare Staffing Names Laurie Reichert President, Domestic Staffing

Indeterminate GlobeNewswire

18 hours ago

Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update

Indeterminate GlobeNewswire

Aug. 19, 2026

DNA X, Inc. Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 19, 2026

Merit Medical Announces Global Operations Leadership Transition

Indeterminate GlobeNewswire

Aug. 19, 2026

Regeneron Announces Investor Conference Presentations

Indeterminate GlobeNewswire

Aug. 19, 2026

Longeveron Appoints Nirav Jhaveri as Chief Financial Officer

Indeterminate GlobeNewswire

Aug. 19, 2026

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 19, 2026

Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 19, 2026

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 19, 2026

Edesa Biotech Announces Proposed Public Offering

Indeterminate GlobeNewswire

Aug. 19, 2026

FDA Authorizes First-of-Its-Kind Robotic Blood Draw Device

Indeterminate GlobeNewswire

Aug. 19, 2026

Southern Sky Brands Announces Three New Vape Products in Collaboration with Martin’s in Jackson, Mississippi, Portions of Proceeds to Benefit Veterans Charity

Indeterminate GlobeNewswire

Aug. 19, 2026

What Clinicians Evaluate Before Prescribing Low Dose Naltrexone Online

Indeterminate GlobeNewswire

Aug. 19, 2026

Pasatru™ (garetosmab-grts) First and Only FDA-approved Treatment Demonstrating Reduction in New Heterotopic Ossification (HO) Lesions and Clinician-Assessed Flare-ups in a Placebo-controlled Trial in Adults with Fibrodysplasia Ossificans Progressiva…

Indeterminate GlobeNewswire